東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The neuropathology of frontotemporal...

Bieniek, Kevin Frank.

Linked to FindBook

Google Book

Amazon

博客來

The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion./
Author:	Bieniek, Kevin Frank.
Description:	211 p.
Notes:	Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
Contained By:	Dissertation Abstracts International77-10B(E).
Subject:	Neurosciences. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10111546
ISBN:	9781339747552

The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion.
Bieniek, Kevin Frank.

The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion. - 211 p.

Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.

Thesis (Ph.D.)--College of Medicine - Mayo Clinic, 2016.

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two debilitating and relatively common early-onset neurodegenerative disorders along a clinicopathologic spectrum. Accounting for ~25% of familial FTD and ~30% of familial ALS, a GGGGCC hexanucleotide repeat expansion in chromosome 9 open reading-frame 72 (C9ORF72) is the most common known genetic cause of both disorders (c9FTD/ALS). While many neuropathologic features of c9FTD/ALS cases mirror archetypal FTD/ALS [i.e., focal neuronal loss, TAR DNA-binding protein 43 (TDP-43) pathology, etc.], a subset of neuronal lesions have been observed which are positive for ubiquitin, but negative for TDP-43, suggesting additional underlying pathology. Our goal of this study was to eliminate the possibility of the involvement other classic neurodegenerative protein (tau and amyloid-beta) and identify novel aggregating proteins which could potentially serve as biomarkers and therapeutic targets. Using quantitative neuropathologic assessment, we demonstrated tau and amyloid-beta did not consistently co-localize with these ubiquitinated inclusions and was not more common in c9FTD/ALS compared to sporadic FTD and ALS cases (as well as FTD cases with another known mutation, GRN). Following insights from the field of trinucleotide repeat disorders, we discovered novel pathologic dipeptide repeats in c9FTD/ALS generated through the process of repeat-associated non-ATG (RAN) translation. These dipeptide repeat proteins had a very characteristic and consistent morphology, distribution, and pathologic burden amongst c9FTD/ALS cases. These proteins were also highly specific to C9ORF72 repeat expansion carriers, even in clinically and neuropathologically atypical cases. Subsequent research from this initial finding has not only confirmed our results, but also demonstrated the toxicity of these proteins and even their therapeutic potential towards ameliorating disease in individuals harboring the C9ORF72 expansion.

ISBN: 9781339747552Subjects--Topical Terms:

588700
Neurosciences.

The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion.
LDR:02958nmm a2200289 4500 001 2074325
005 20160926125813.5
008 170521s2016 ||||||||||||||||| ||eng d
020 $a 9781339747552
035 $a (MiAaPQ)AAI10111546
035 $a AAI10111546
040 $a MiAaPQ $c MiAaPQ
100 1 $a Bieniek, Kevin Frank. $3 3189627
245 1 4 $a The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion.
300 $a 211 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
500 $a Adviser: Dennis W. Dickson.
502 $a Thesis (Ph.D.)--College of Medicine - Mayo Clinic, 2016.
520 $a Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two debilitating and relatively common early-onset neurodegenerative disorders along a clinicopathologic spectrum. Accounting for ~25% of familial FTD and ~30% of familial ALS, a GGGGCC hexanucleotide repeat expansion in chromosome 9 open reading-frame 72 (C9ORF72) is the most common known genetic cause of both disorders (c9FTD/ALS). While many neuropathologic features of c9FTD/ALS cases mirror archetypal FTD/ALS [i.e., focal neuronal loss, TAR DNA-binding protein 43 (TDP-43) pathology, etc.], a subset of neuronal lesions have been observed which are positive for ubiquitin, but negative for TDP-43, suggesting additional underlying pathology. Our goal of this study was to eliminate the possibility of the involvement other classic neurodegenerative protein (tau and amyloid-beta) and identify novel aggregating proteins which could potentially serve as biomarkers and therapeutic targets. Using quantitative neuropathologic assessment, we demonstrated tau and amyloid-beta did not consistently co-localize with these ubiquitinated inclusions and was not more common in c9FTD/ALS compared to sporadic FTD and ALS cases (as well as FTD cases with another known mutation, GRN). Following insights from the field of trinucleotide repeat disorders, we discovered novel pathologic dipeptide repeats in c9FTD/ALS generated through the process of repeat-associated non-ATG (RAN) translation. These dipeptide repeat proteins had a very characteristic and consistent morphology, distribution, and pathologic burden amongst c9FTD/ALS cases. These proteins were also highly specific to C9ORF72 repeat expansion carriers, even in clinically and neuropathologically atypical cases. Subsequent research from this initial finding has not only confirmed our results, but also demonstrated the toxicity of these proteins and even their therapeutic potential towards ameliorating disease in individuals harboring the C9ORF72 expansion.
590 $a School code: 1542.
650 4 $a Neurosciences. $3 588700
650 4 $a Pathology. $3 643180
650 4 $a Genetics. $3 530508
690 $a 0317
690 $a 0571
690 $a 0369
710 2 $a College of Medicine - Mayo Clinic. $b Neurobiology of Disease. $3 3189628
773 0 $t Dissertation Abstracts International $g 77-10B(E).
790 $a 1542
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10111546